PhRMA International Affairs Transition: Ritter To Succeed Herzfeld As Head
This article was originally published in The Pink Sheet Daily
Executive Summary
Shannon Herzfeld will leave the association at the end of the year. Assistant General Counsel Geralyn Ritter is promoted to VP-international affairs and will work with Herzfeld during the transition period.
You may also be interested in...
PhRMA Deputy VP Darragh Joining BIO To Oversee Food & Ag Issues
Darragh brings experience with international intellectual property issues from PhRMA to new post at BIO. He will report to outgoing BIO President Feldbaum, and answer to BIO’s Food & Ag membership.
GSK's Nucala Is Significantly Overpriced, ICER Draft Report Finds
New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.
Deal Watch: Sanofi, Boehringer Swap Side Businesses
Busy week for AstraZeneca sees buyout of Acerta and acquisition of remaining Daliresp/Daxas worldwide rights from Takeda. Amgen and GSK undo their cancer drug alliances from 2009 and 2010, with all rights reverting to the big biotech.